The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment

Published:2020-05-22 Issue:6 Volume:29 Page:567-582
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Buckens Oscar J¹²,El Hassouni Btissame²,Giovannetti Elisa²³,Peters Godefridus J²⁴

Affiliation:

1. Amsterdam University College, Amsterdam, The Netherlands

2. Laboratory Medical Oncology, Amsterdam UMC Location VUMC, CCA, Amsterdam, The Netherlands

3. Pharmacology Lab, AIRC Start up Unit, Fondazione Pisana per La Scienza, Pisa, Italy

4. Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1762566

Reference164 articles.

1. Ephrins and their Eph receptors: multitalented directors of embryonic development

2. Eph receptors and ephrins as targets for cancer therapy

3. Mechanisms of ephrin–Eph signalling in development, physiology and disease

4. Crystal structure of an Eph receptor–ephrin complex

5. A role of the SAM domain in EphA2 receptor activation

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance;World Journal of Gastrointestinal Oncology;2024-09-15

2. Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile;Journal of Drug Targeting;2024-08-02

3. A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets;Frontiers in Oncology;2024-06-17

4. Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile;2024-06-01

5. Co-Delivery of siRNA and Docetaxel to Cancer Cells by NLC for Therapy;ACS Omega;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3